Garthwaite Michael P. sold $50K of EP-PC

Garthwaite Michael P. (VP (Pres., Products Pipelines)) sold 1,550 shares of KINDER MORGAN, INC. (EP-PC) at $32.52 on 2026-07-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Garthwaite Michael P.
Published Jul 20, 2026, 10:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 20, 2026, 10:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$EP-PC
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

Because it is a planned 10b5-1 open-market sale by an officer, it is unlikely to change valuation expectations or near-term trading materially.

02

Market read

Primarily a compliance disclosure; any trading impact is likely limited to short-term sentiment noise.

03

What to watch

The filing does not indicate intent beyond the plan, and the sale size ($50.4k) is typically small relative to company market cap.

Relevance 2/10Novelty 2/10Timing: Filed 2026-07-20, reflecting a sale executed 2026-07-16.

Background

The article is an SEC Form 4 insider transaction disclosure for Kinder Morgan, Inc. (EP-PC).

Market effects

No clear sector read-through; this is an individual insider transaction rather than a sector catalyst.

None indicated.

None indicated.

Counterpoint

Some traders may interpret insider selling as mild caution, but the 10b5-1 structure reduces interpretability.

Key entities

  • Kinder Morgan, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Garthwaite Michael P.

    VP (Pres., Products Pipelines) who sold 1,550 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).